Search results
Moderna's CEO wants employees to use ChatGPT at least 20 times a day
Quartz· 2 weeks agoStéphane Bancel said the pharma company's partnership with OpenAI will help transform its business
State’s highest paid CEO reports major drop in compensation - Boston Business Journal
The Business Journals· 2 weeks agoLast year, Douglas Ingram, the president and CEO of Sarepta Therapeutics (Nasdaq: SRPT), reported...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 6 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Tech Bytes: Moderna partners with OpenAI to expedite drug development processes
Proactive Investors· 1 day agoWith a valuation of US$47 billion (~A$71 billion), Moderna aims to leverage AI to automate functions...
Moderna and OpenAI Collaborate To Advance mRNA Medicine
San Mateo Daily Journal· 2 weeks agoCAMBRIDGE, MA AND SAN FRANCISCO, CA / ACCESSWIRE / April 24, 2024 / Moderna, Inc. (NASDAQ:MRNA) and OpenAI today announced their ongoing ...
Moderna stock gains on OpenAI deal (NASDAQ:MRNA)
Seeking Alpha· 2 weeks agoModerna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines. Read more here.
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 6 days agoGood morning, everyone, and thank you for joining us on today's call to discuss Moderna's first-quarter 2024 financial results and business ...
Moderna Shares Jump After Better-Than-Expected Sales
The Wall Street Journal· 6 days agoModerna shares shot up about 7% Thursday after reporting better-than-expected quarterly sales and signaling confidence in a sales pickup later this year...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 5 days agoWith its OpenAI partnership, Moderna hopes to implement AI across its business, with a goal to bring...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 5 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...